Yeboah J, et al. Utility of nontraditional risk markers in individuals ineligible for statin therapy according to the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines. Circulation 2015;132:916-922.SOURCES:
Superko HR. Nontraditional markers of cardiovascular disease risk can improve the 2013 American College of Cardiology/American Heart Association Prevention Guidelines: Insights from the multi-ethnic study of atherosclerosis investigation. Circulation 2015;132:904-906.